Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
Vumerity
DRUG
2 trials
Sponsors
University of Nebraska
, University of Colorado, Denver
Conditions
Multiple Sclerosis (MS) Relapsing Remitting
Peripheral Arterial Disease
Peripheral Arterial Occlusive Disease
Peripheral Artery Disease
Peripheral Vascular Diseases
Early Phase 1
Impact of Nrf2 Activation on Macrovascular, Microvascular & Leg Function & Walking Capacity in Peripheral Artery Disease
Recruiting
NCT06319339
University of Nebraska
Peripheral Artery Disease, Peripheral Vascular Diseases, Peripheral Arterial Disease +1
Start: 2024-11-14
End: 2026-12-01
Target: 20
Updated: 2026-06-24
Unknown Phase
Prospective Evaluation of De-Escalation From antiCD-20 Therapies to Dimethyl Fumarate (Tecfidera) or Diroximel Fumarate (Vumerity)
Active, not recruiting
NCT07757568
University of Colorado, Denver
Multiple Sclerosis (MS) Relapsing Remitting
Start: 2023-03-07
End: 2026-11-07
Updated: 2026-08-11